Merck names Baxter exec as CFO

Merck (MRK) has appointed Robert Davis as CFO to replace replace Peter Kellogg as of April 23.

Davis is joining Merck from Baxter, where he is president of the company's medical products business.

News of Davis' appointment comes as Baxter announces that it's splitting into two companies, with one focused on biopharmaceuticals and the other on medical products. (PR)

From other sites
Comments (1)
  • lrlz17
    , contributor
    Comments (45) | Send Message
    Very suspicious exit by Peter Kellogg.
    27 Mar 2014, 09:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs